Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2025-12-24 @ 10:50 PM
NCT ID: NCT05062369
Eligibility Criteria: Inclusion Criteria: * Meet the Diagnostic and Statistical Manual of Mental Disorders diagnostic criteria for AUD * Abstinent from alcohol use * Must have the intention to remain in the Lodging Plus program until the end of the intervention portion of the study. Exclusion Criteria: * Any medical condition or treatment with neurological sequelae (i.e. stroke, tumor, loss of consciousness\>30 min, HIV) * A head injury resulting in a skull fracture or a loss of consciousness exceeding 30 minutes (i.e., moderate or severe TBI) * Any contraindications for tDCS or MRI scanning (tDCS contraindication: history of seizures; MRI contraindications; metal implants, pacemakers or any other implanted electrical device, injury with metal, braces, dental implants, non-removable body piercings, pregnancy, breathing or moving disorder) * Any primary psychotic disorder (e.g. schizophrenia, schizoaffective disorder); Participants with other treated and stable psychiatric disorders will be included * Presence of a condition that would render study measures difficult or impossible to administer or interpret * Primary current substance use disorder diagnosis on a substance other than alcohol except for caffeine or nicotine * Clinical evidence for Wernicke-Korsakoff syndrome * Left-handedness * Entrance to the treatment program under a court mandate
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT05062369
Study Brief:
Protocol Section: NCT05062369